- Previous Close
138.35 - Open
138.35 - Bid 140.40 x --
- Ask 142.90 x --
- Day's Range
138.35 - 145.90 - 52 Week Range
129.10 - 200.85 - Volume
6,414 - Avg. Volume
10,173 - Market Cap (intraday)
1.448B - Beta (5Y Monthly) 0.71
- PE Ratio (TTM)
10.67 - EPS (TTM)
13.24 - Earnings Date May 26, 2025 - May 30, 2025
- Forward Dividend & Yield 2.50 (1.77%)
- Ex-Dividend Date Sep 23, 2024
- 1y Target Est
--
Tyche Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients and intermediates in India and internationally. It also provides chiral intermediates and nutraceuticals; and contract drug substance and analytical development, as well as contract development, manufacturing, and analytical development services. The company primarily exports its products to the United States and Europe. Tyche Industries Limited was incorporated in 1998 and is based in Hyderabad, India.
www.tycheindustries.net164
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: TYCHE.BO
View MorePerformance Overview: TYCHE.BO
Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TYCHE.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TYCHE.BO
View MoreValuation Measures
Market Cap
1.45B
Enterprise Value
803.99M
Trailing P/E
10.67
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.15
Price/Book (mrq)
1.09
Enterprise Value/Revenue
1.19
Enterprise Value/EBITDA
3.95
Financial Highlights
Profitability and Income Statement
Profit Margin
20.10%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
674.77M
Net Income Avi to Common (ttm)
135.65M
Diluted EPS (ttm)
13.24
Balance Sheet and Cash Flow
Total Cash (mrq)
644.34M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--